The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus.
Mingjun FengHuaming LinBin HeBinhao WangXiaomin ChenHuimin ChuPublished in: Journal of healthcare engineering (2021)
Low-dose NOACs are a safe and effective option for the treatment of LAAT in some special subset patients. However, the results warrant validation in a prospective study.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- left atrial appendage
- low dose
- catheter ablation
- left atrial
- end stage renal disease
- direct oral anticoagulants
- high dose
- newly diagnosed
- chronic kidney disease
- heart failure
- prognostic factors
- ejection fraction
- peritoneal dialysis
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- patient reported outcomes
- left ventricular
- venous thromboembolism
- mitral valve